Skip to main content
Scheme 1: | Cancer Nanotechnology

Scheme 1:

From: Ultrasound-activated nano-TiO2 loaded with temozolomide paves the way for resection of chemoresistant glioblastoma multiforme

Scheme 1:

Illustration of TiO2 nanosticks-loaded temozolomide treatment and activation by ultrasound to ablate the TMZ-resistant glioblastoma multiforme. The ultrasound has a triple action therapeutic effect on GBM by (I) enhancing the nanomedicine permeability, (II) release of TMZ from TiO2 nanosticks, and (III) generation of reactive oxygen species for sensitization of GBM to TMZ

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us